Insider · CIK 0001542517
Adam S Grossman
Files at ADMA (ADMA BIOLOGICS, INC.). First filing Nov 22, 2024, latest Mar 17, 2026.
In brief
Adam S Grossman files SEC Form 4 as CEO, president and director at ADMA (ADMA BIOLOGICS, INC.). Since Nov 22, 2024, Adam S Grossman has reported 0 open-market buys worth $0 and 13 open-market sells worth $5.6M, the latest filed on Mar 17, 2026.
A track record needs three past buys with six months of prices behind them; Adam S Grossman has 0, so none is measured yet.
The newest scored trade: sold $318k of ADMA on Mar 16, 2026, filed Mar 17, 2026, scored 12 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $1.7M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADMA: ADMA BIOLOGICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | ADMA BIOLOGICS, INC. | $318k 21,000 shares | -1% | +13% from low-35% from high | |
| 5Weak | ADMA BIOLOGICS, INC. | $338k 21,000 shares | -1% | +14% from low-35% from high | |
| 6Weak | ADMA BIOLOGICS, INC. | $416k 21,000 shares | -1% | +41% from low-20% from high | |
| 5Weak | ADMA BIOLOGICS, INC. | $336k 21,000 shares | -1% | +14% from low-35% from high | |
| 5Weak | ADMA BIOLOGICS, INC. | $336k 21,000 shares | -1% | +9% from low-38% from high | |
| 5Weak | ADMA BIOLOGICS, INC. | $339k 21,000 shares | -1% | 0% from low-38% from high | |
| 5Weak | ADMA BIOLOGICS, INC. | $354k 21,000 shares | -1% | +10% from low-31% from high | |
| 6Weak | ADMA BIOLOGICS, INC. | $392k 21,000 shares | -1% | +16% from low-27% from high | |
| 22Weak | ADMA BIOLOGICS, INC. | $437k 21,000 shares | -1% | +32% from low-17% from high | |
| 14Weak | ADMA BIOLOGICS, INC. | $408k 21,000 shares | -1% | +24% from low-22% from high | |
| 7Weak | ADMA BIOLOGICS, INC. | $451k 21,000 shares | -1% | +43% from low-2% from high | |
| 6Weak | ADMA BIOLOGICS, INC. | $397k 21,000 shares | -1% | +33% from low-9% from high | |
| 58Moderate | ADMA BIOLOGICS, INC. | $1.0M 48,967 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | 84,000 0.04% of outstanding | $1.4M | Feb 17, 2026 | $752k |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | 63,000 0.03% of outstanding | $961k | Oct 24, 2025 | $693k |
| Jul 15, 2025 | ADMA ADMA BIOLOGICS, INC. | 63,000 0.03% of outstanding | $1.2M | Jul 15, 2025 | $1.3M |
| Mar 19, 2025 | ADMA ADMA BIOLOGICS, INC. | 84,000 0.04% of outstanding | $1.6M | Mar 19, 2025 | none |
| Nov 22, 2024 | ADMA ADMA BIOLOGICS, INC. | 48,967 0.02% of outstanding | $1.0M | Nov 22, 2024 | $11M |
Transactions
The newest 50 of 62 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,133,777 | Mar 17, 2026 |
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $15.16 | $227k | 2,118,777 | Mar 17, 2026 |
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $15.16 | $91k | 2,112,777 | Mar 17, 2026 |
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 690,950 | Mar 17, 2026 |
| Mar 6, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -56,438 | $15.39 | $869k | 2,148,290 | Mar 10, 2026 |
| Mar 7, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -29,513 | $15.39 | $454k | 2,118,777 | Mar 10, 2026 |
| Feb 26, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -54,858 | $15.18 | $833k | 2,204,728 | Mar 2, 2026 |
| Feb 19, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -24,793 | $16.32 | $405k | 2,259,586 | Feb 23, 2026 |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,305,379 | Feb 17, 2026 |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.08 | $241k | 2,290,379 | Feb 17, 2026 |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.08 | $96k | 2,284,379 | Feb 17, 2026 |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 705,950 | Feb 17, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +282,529 | $0.00 | $0 | 2,290,379 | Feb 11, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (right to buy)derivative | +444,711 | $0.00 | $0 | 444,711 | Feb 11, 2026 |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,028,850 | Dec 16, 2025 |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $19.79 | $297k | 2,013,850 | Dec 16, 2025 |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $19.79 | $119k | 2,007,850 | Dec 16, 2025 |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 720,950 | Dec 16, 2025 |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,034,850 | Nov 21, 2025 |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.00 | $240k | 2,019,850 | Nov 21, 2025 |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.00 | $96k | 2,013,850 | Nov 21, 2025 |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 735,950 | Nov 21, 2025 |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,040,850 | Oct 24, 2025 |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.00 | $240k | 2,025,850 | Oct 24, 2025 |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.00 | $96k | 2,019,850 | Oct 24, 2025 |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 750,950 | Oct 24, 2025 |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,046,850 | Sep 16, 2025 |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.13 | $242k | 2,031,850 | Sep 16, 2025 |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.13 | $97k | 2,025,850 | Sep 16, 2025 |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 765,950 | Sep 16, 2025 |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,052,850 | Aug 15, 2025 |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.88 | $253k | 2,037,850 | Aug 15, 2025 |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.88 | $101k | 2,031,850 | Aug 15, 2025 |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 780,950 | Aug 15, 2025 |
| Jul 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,058,850 | Jul 16, 2025 |
| Jul 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $18.66 | $280k | 2,043,850 | Jul 16, 2025 |
| Jul 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $18.66 | $112k | 2,037,850 | Jul 16, 2025 |
| Jul 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 795,950 | Jul 16, 2025 |
| Jun 16, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,064,850 | Jun 18, 2025 |
| Jun 16, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $20.81 | $312k | 2,049,850 | Jun 18, 2025 |
| Jun 16, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $20.81 | $125k | 2,043,850 | Jun 18, 2025 |
| Jun 16, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 810,950 | Jun 18, 2025 |
| May 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,070,850 | May 16, 2025 |
| May 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $19.45 | $292k | 2,055,850 | May 16, 2025 |
| May 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $19.45 | $117k | 2,049,850 | May 16, 2025 |
| May 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 825,950 | May 16, 2025 |
| Apr 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,076,850 | Apr 16, 2025 |
| Apr 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $21.46 | $322k | 2,061,850 | Apr 16, 2025 |
| Apr 15, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $21.46 | $129k | 2,055,850 | Apr 16, 2025 |
| Apr 15, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 840,950 | Apr 16, 2025 |
Questions about Adam S Grossman
Answered from the filings on this page, as of the latest one.
Is Adam S Grossman buying or selling?
In the last 12 months Adam S Grossman reported 0 open-market buys worth $0 and 5 open-market sells worth $1.7M on SEC Form 4; the latest was sold $318k of ADMA on Mar 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Adam S Grossman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam S Grossman has 0.
Where does Adam S Grossman file Form 4?
Adam S Grossman has filed Form 4 at ADMA (ADMA BIOLOGICS, INC.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.